April 21, 2014 7:04 AM ET

Pharmaceuticals

Company Overview of Barrier Therapeutics, Inc.

Company Overview

Barrier Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products in the field of dermatology. It markets Xolegel, a topical gel for the treatment of seborrheic dermatitis; Vusion, a topical ointment for the treatment of infants and children with diaper dermatitis; and Solage, a topical solution for the treatment of solar lentigines. The company’s product pipeline includes Hyphanox in Phase III clinical trial for the treatment of onychomycosis; Pramiconazole in Phase IIa clinical trial for the treatment of onychomycosis, and skin and mucosal fungal infections; and Oral Rambazole in Phase IIb clinical trial for the treatment of psoriasis. Its pipeline port...

600 College Road East

Suite 3200

Princeton, NJ 08540-6636

United States

Founded in 2001

128 Employees

Phone:

609-945-1200

Fax:

609-945-1212

Key Executives for Barrier Therapeutics, Inc.

Chief Financial Officer
Age: 54
Global Head of Supply Chain and Trade Relations
Secretary and General Counsel
Age: 43
Chief Scientific Officer
Age: 70
Compensation as of Fiscal Year 2013.

Similar Private Companies By Industry

Company Name Region
Lithera, Inc. United States
Biotecnol Pharmaceuticals, Inc. United States
Albion Medical Holdings, Inc. United States
AmpliMed Corporation United States
ChronoRX LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Barrier Therapeutics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.